RhumbLine Advisers’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,088
| Closed | -$2.59K | – | 4269 |
|
|
2024
Q2 | $2.59K | Hold |
2,088
| – | – | ﹤0.01% | 4163 |
|
|
2024
Q1 | $2.71K | Hold |
2,088
| – | – | ﹤0.01% | 4057 |
|
|
2023
Q4 | $2.61K | Hold |
2,088
| – | – | ﹤0.01% | 4068 |
|
|
2023
Q3 | $2.71K | Sell |
2,088
-4,168
| -67% | -$5.42K | ﹤0.01% | 4078 |
|
|
2023
Q2 | $10.8K | Sell |
6,256
-55,903
| -90% | -$96.2K | ﹤0.01% | 3931 |
|
|
2023
Q1 | $91K | Buy |
62,159
+849
| +1% | +$1.24K | ﹤0.01% | 2864 |
|
|
2022
Q4 | $99K | Buy |
61,310
+81
| +0.1% | +$131 | ﹤0.01% | 2905 |
|
|
2022
Q3 | $205K | Buy |
61,229
+4,974
| +9% | +$16.7K | ﹤0.01% | 2887 |
|
|
2022
Q2 | $205K | Buy |
56,255
+7,527
| +15% | +$27.4K | ﹤0.01% | 2919 |
|
|
2022
Q1 | $352K | Sell |
48,728
-2,657
| -5% | -$19.2K | ﹤0.01% | 2584 |
|
|
2021
Q4 | $698K | Sell |
51,385
-604
| -1% | -$8.21K | ﹤0.01% | 2364 |
|
|
2021
Q3 | $1.09M | Buy |
51,989
+1,743
| +3% | +$36.5K | ﹤0.01% | 2190 |
|
|
2021
Q2 | $1.2M | Buy |
50,246
+35,056
| +231% | +$839K | ﹤0.01% | 2161 |
|
|
2021
Q1 | $445K | Buy |
15,190
+2,034
| +15% | +$59.6K | ﹤0.01% | 2542 |
|
|
2020
Q4 | $393K | Buy |
+13,156
| New | +$393K | ﹤0.01% | 2542 |
|